Laury Finn
- Pulmonary and Respiratory Medicine top 10%
- Surgery top 10%
- Oncology top 10%
- Molecular Biology
- Cancer Research
- Co-authors
- Christopher J. LogothetisAvishay SellaRobert J. AmatoR. J. AmatoJulie A. EllerhorstRobert G. KilbournDanai DalianiMeletios Α. Dimopoulos
- Topics
- Prostate Cancer Treatment and Research (6 papers)Bladder and Urothelial Cancer Treatments (5 papers)Prostate Cancer Diagnosis and Treatment (5 papers)
- Partner nations
- United StatesSpainIsrael
In The Last Decade
Laury Finn
21 papers receiving 640 citations
Peers
Comparison fields: 5 of 55
- Pulmonary and Respiratory Medicine 302
- Surgery 282
- Oncology 241
- Molecular Biology 164
- Cancer Research 123
Countries citing papers authored by Laury Finn
This map shows the geographic impact of Laury Finn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laury Finn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laury Finn more than expected).
Fields of papers citing papers by Laury Finn
This network shows the impact of papers produced by Laury Finn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laury Finn. The network helps show where Laury Finn may publish in the future.
Co-authorship network of co-authors of Laury Finn
This figure shows the co-authorship network connecting the top 25 collaborators of Laury Finn. A scholar is included among the top collaborators of Laury Finn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laury Finn. Laury Finn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 17 | |
| 3 | 23 | |
| 4 | Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer. | 117 |
| 5 | 6 | |
| 6 | 1 | |
| 7 | 37 | |
| 8 | 2 | |
| 9 | 3 | |
| 10 | Phase II trial of 5-fluorouracil, interferon-alpha and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma. | 49 |
| 11 | 1 | |
| 12 | 32 | |
| 13 | 43 | |
| 14 | 18 | |
| 15 | 1 | |
| 16 | 25 | |
| 17 | 11 | |
| 18 | 31 | |
| 19 | 86 | |
| 20 | 11 |
About Laury Finn
Laury Finn is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Biotechnology, having authored 22 papers that have together received 671 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (6 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (302 citations), Oncology (241 citations) and Cancer Research (123 citations). Laury Finn has collaborated with scholars based in United States, Spain and Israel. Frequent co-authors include Christopher J. Logothetis, Avishay Sella, Robert J. Amato, R. J. Amato, Julie A. Ellerhorst, Robert G. Kilbourn, Danai Daliani, Meletios Α. Dimopoulos, Habib M. Ghaddar and William D. Figg. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.